{"id":"https://openalex.org/W4362546201","doi":"https://doi.org/10.1158/2326-6066.c.6549094.v1","title":"Data from A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge","display_name":"Data from A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362546201","doi":"https://doi.org/10.1158/2326-6066.c.6549094.v1"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.c.6549094.v1","doi":"https://doi.org/10.1158/2326-6066.c.6549094.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2326-6066.c.6549094.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/2326-6066.c.6549094.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029459014","display_name":"Elizabeth K. Duperret","orcid":"https://orcid.org/0000-0003-1640-4205","observed_orcids":["https://orcid.org/0000-0003-1640-4205"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth K. Duperret","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071613924","display_name":"Alfredo Perales\u2010Puchalt","orcid":"https://orcid.org/0000-0003-4904-5050","observed_orcids":["https://orcid.org/0000-0003-4904-5050"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alfredo Perales-Puchalt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044108372","display_name":"Regina Stoltz","orcid":"https://orcid.org/0000-0002-2063-8840","observed_orcids":["https://orcid.org/0000-0002-2063-8840"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Regina Stoltz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017958517","display_name":"Hiranjith G.H.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiranjith G.H.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048280548","display_name":"Nitin Mandloi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nitin Mandloi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"James Barlow","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James Barlow","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047179282","display_name":"Amitabha Chaudhuri","orcid":"https://orcid.org/0000-0002-1493-9874","observed_orcids":["https://orcid.org/0000-0002-1493-9874"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amitabha Chaudhuri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049047352","display_name":"Niranjan Y. Sardesai","orcid":"https://orcid.org/0000-0001-6920-1167","observed_orcids":["https://orcid.org/0000-0001-6920-1167"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Niranjan Y. Sardesai","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6920-1167","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5023265367","display_name":"David B. Weiner","orcid":"https://orcid.org/0000-0002-2232-8512","observed_orcids":["https://orcid.org/0000-0002-2232-8512"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David B. Weiner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.020999999716877937,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dna-vaccine","display_name":"DNA vaccine","score":0.6809999942779541},{"id":"https://openalex.org/keywords/neoantigens","display_name":"neoantigens","score":0.9190000295639038},{"id":"https://openalex.org/keywords/mhc-class-i","display_name":"MHC class I","score":0.8420000076293945},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.9580000042915344},{"id":"https://openalex.org/keywords/t-cell-epitopes","display_name":"T cell epitopes","score":0.7429999709129333},{"id":"https://openalex.org/keywords/electroporation","display_name":"electroporation","score":0.8629999756813049},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8650000095367432},{"id":"https://openalex.org/keywords/personalized-cancer-immunotherapy","display_name":"personalized cancer immunotherapy","score":0.6949999928474426},{"id":"https://openalex.org/keywords/neoantigen-specific-t-cells","display_name":"neoantigen-specific T cells","score":0.5770000219345093}],"concepts":[{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.654660165309906},{"id":"https://openalex.org/C170627219","wikidata":"https://www.wikidata.org/wiki/Q13218497","display_name":"MHC class I","level":4,"score":0.6197360754013062},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5597667098045349},{"id":"https://openalex.org/C167508917","wikidata":"https://www.wikidata.org/wiki/Q578537","display_name":"DNA vaccination","level":4,"score":0.5492952466011047},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5266240239143372},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.500626802444458},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.4842343330383301},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.4408857822418213},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4360000193119049},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.4312335252761841},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.42343825101852417},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.41672155261039734},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4029465317726135},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3738865554332733},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.36549848318099976},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.34105896949768066},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1267385184764862},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11769488453865051},{"id":"https://openalex.org/C2780801004","wikidata":"https://www.wikidata.org/wiki/Q1415366","display_name":"Immunization","level":3,"score":0.09438478946685791}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6066.c.6549094.v1","doi":"https://doi.org/10.1158/2326-6066.c.6549094.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2326-6066.c.6549094.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2326-6066.c.6549094.v1","doi":"https://doi.org/10.1158/2326-6066.c.6549094.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2326-6066.c.6549094.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2912067875","https://openalex.org/W3021034179","https://openalex.org/W7161051686","https://openalex.org/W4393333828","https://openalex.org/W2972113529","https://openalex.org/W4308401416","https://openalex.org/W3081458975","https://openalex.org/W3157007328","https://openalex.org/W7122396372","https://openalex.org/W4415900163"],"abstract_inverted_index":{"Abstract":[0],"T-cell":[1,91,104,144],"recognition":[2],"of":[3,72,137],"cancer":[4],"neoantigens":[5],"is":[6],"important":[7],"for":[8,146],"effective":[9],"immune-checkpoint":[10],"blockade":[11],"therapy,":[12],"and":[13,28,34,84,117],"an":[14],"increasing":[15],"interest":[16],"exists":[17],"in":[18,32,115],"developing":[19],"personalized":[20],"tumor":[21,65,73,127],"neoantigen":[22,30,108,147],"vaccines.":[23],"Previous":[24],"studies":[25,37],"utilizing":[26,58],"RNA":[27],"long-peptide":[29],"vaccines":[31,109],"preclinical":[33,56],"early-phase":[35],"clinical":[36],"have":[38],"shown":[39],"immune":[40],"responses":[41],"predominantly":[42,86],"driven":[43],"by":[44,77],"MHC":[45,87,94],"class":[46,88,95],"II":[47],"CD4+":[48],"T":[49,119],"cells.":[50],"Here,":[51],"we":[52],"report":[53],"on":[54],"a":[55,59,111,134],"study":[57],"DNA":[60,80,107,139],"vaccine":[61],"platform":[62,140],"to":[63,141],"target":[64],"neoantigens.":[66],"We":[67],"showed":[68],"that":[69],"optimized":[70],"strings":[71],"neoantigens,":[74],"when":[75],"delivered":[76],"potent":[78],"electroporation-mediated":[79],"delivery,":[81],"were":[82],"immunogenic":[83,102],"generated":[85],"I\u2013restricted,":[89],"CD8+":[90,103,143],"responses.":[92],"High":[93],"I":[96],"affinity":[97],"was":[98],"associated":[99],"specifically":[100],"with":[101],"epitopes.":[105],"These":[106,131],"induced":[110],"therapeutic":[112],"antitumor":[113],"response":[114],"vivo,":[116],"neoantigen-specific":[118],"cells":[120,128],"expanded":[121],"from":[122],"immunized":[123],"mice":[124],"directly":[125],"killed":[126],"ex":[129],"vivo.":[130],"data":[132],"illustrate":[133],"unique":[135],"advantage":[136],"this":[138],"drive":[142],"immunity":[145],"immunotherapy.":[148]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2023-04-06T00:00:00"}